How Many Patients Suffering Major Trauma Would be Eligible for a Pre-hospital Transfusion
ConditionTrauma Injury
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHôpital NOVO
About this trial
The aim of the study is to measure the number of patients being cared for by a medical team for major trauma who could benefit from a transfusion labile blood products and thus provide a scientific argument in favour of supplying labile blood products to pre-hospital
Eligibility criteria
Qualifiers
Patients over 18
Taken care of by a MICU team from participating centres
Victims of major trauma requiring transport to an emergency/recovery unit or declared dead during care
Informed and did not object to the collection of his data for research purposes during his lifetime
Disqualifiers
Traumatological reason for departure not confirmed in the emergency medical services report
Patient care of by the MICU for secondary transport (transport from one hospital to another)
Patient died without resuscitation by a professional
Patient with manifest isolated closed head injury
Trial design
Treatments tested in this trial
- Data Collection
Treatment groups
200 Participants
are divided into 1 treatment groupSponsors and collaborators
Hôpital NOVO
Lead sponsor
Direction Centrale du Service de Santé des Armées
Collaborator
Source ClinicalTrials.gov